Biomarkers that characterize transition of AKI to CKD, such as urinary thioredoxin—a redox regulating protein—or urinary serpinA3/alpha-1-antichymotrypsin and angiotensinogen, are the subject of extensive, ongoing research [24,25]. This evidence concerns the gene SERPINA3 and chronic kidney disease.